CTY Stock Analysis Today
Updated Nov 7, 2026 · trends, key levels, insider activity and news
Is CTY bullish or bearish today?
Daily trend: Uptrend (confirmed) — turns down below $25.23
SEPT signal: Distribution · Consolidating
CTY trend by timeframe
| Daily | Uptrend (confirmed) |
|---|---|
| 4 hour | Strong Bearish |
| 1 hour | Leaning Bullish |
| 15 min | Bullish |
| 5 min | Symmetric Triangle |
Trends are calculated from price structure and update during market hours.
CTY support and resistance levels
Resistance (above)
$17.263 touches
$19.7511 touches
$21.151 touches
Support (below)
$11.031 touches
Upside zones: $22.00 / $22.96 / $23.92
See all levels on the live chart →Insider and institutional activity
Insiders
Buy30-day buys / sells
2 / 030-day net
$6.1MHedge fund holders
0Latest CTY news and filings
- SEC FilingSECCity Therapeutics, Inc. filed an insider trading report (Form 4)
Form 4 reports shares bought or sold by company insiders such as officers, directors or large holders.
- SEC FilingSECCity Therapeutics, Inc. filed a report on a major company event (Form 8-K)
Form 8-K tells shareholders about important events such as deals, leadership changes or results.
Live CTY chart with trend icons on every timeframe, key levels, dark pool and options flow, news alerts, and Ask GOAX for a full analysis on demand.
Start free 7-day trialFrequently asked questions
Is CTY bullish or bearish today?
CTY daily trend: Uptrend (confirmed) — turns down below $25.225. SEPT signal: Distribution (Consolidating). Updated Nov 7, 2026.
What is CTY's trend on each timeframe?
Daily: Uptrend (confirmed); 4 hour: Strong Bearish; 1 hour: Leaning Bullish; 15 min: Bullish; 5 min: Symmetric Triangle.
What are CTY support and resistance levels?
Support: $11.03. Resistance: $17.26, $19.75, $21.15. Last price $17.07.
Are insiders buying or selling CTY?
Insider signal: Buy. Last 30 days: 2 buys, 0 sells, net $6.1M.
What is the latest news on CTY?
Oct 19, 2026: City Therapeutics, Inc. filed an insider trading report (Form 4) · Oct 19, 2026: City Therapeutics, Inc. filed a report on a major company event (Form 8-K)